Sugar Maple Asset Management »

Alaunos Therapeutics shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $10 6 1.83

More positions owned by Sugar Maple Asset Management

Abbvie (ABBV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
Abbott Laboratories (ABT)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Silver Tr Ishares (SLV)
Vaneck Etf Trust Clo Etf (CLOI)
T Rowe Price Etf Cap Appreciation (TCAF)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Spdr Series Trust S&p Divid Etf (SDY)

View all positions for Sugar Maple Asset Management

Top funds holding Alaunos Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
Morgan Stanley
Tower Research Capital
UBS Group
Advisor Group Holdings
Atlantic Trust
Royal Bank of Canada
Wells Fargo & Company
Ronald Blue Trust
Steward Partners Investment Advisory
Federation des caisses Desjardins du Quebec
Barclays
Asset Dedication

View all funds holding Alaunos Therapeutics